| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.099 | 0.05 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.05 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.06 |